A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model [Corrigendum]
Klapproth AP, Shevtsov M, Stangl S, Li WB, Multhoff G. Int J Nanomedicine. 2020;15:4677–4689. The authors have advised the author and affiliation list on page 4677 is incorrect. The correct author list and affiliationsare as follows. Alexander P Klapproth1,2,*Max...
Guardado en:
Autores principales: | Klapproth AP, Shevtsov M, Stangl S, Li WB, Multhoff G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/53b9129771da4931875d20be9cdd2c4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model
por: Klapproth AP, et al.
Publicado: (2020) -
Targeting experimental orthotopic glioblastoma with chitosan-based superparamagnetic iron oxide nanoparticles (CS-DX-SPIONs)
por: Shevtsov M, et al.
Publicado: (2018) -
Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging
por: Unterweger H, et al.
Publicado: (2017) -
Targeting Brain Tumors with Mesenchymal Stem Cells in the Experimental Model of the Orthotopic Glioblastoma in Rats
por: Natalia Yudintceva, et al.
Publicado: (2021) -
Preparation and characterization of superparamagnetic iron oxide nanoparticles for magnetically guided drug delivery
por: Kumar P, et al.
Publicado: (2018)